drugset / Trial / NCT01234142

A Study Evaluating the Absorption Of Varenicline Through The Skin Following Once Daily Application Of A Patch For 14 Days

NCT01234142

Phase 1 Completed 45 enrolled Pfizer
RandomizedParallel-groupDouble-blindBasic science

Summary

This study will evaluate the steady-state pharmacokinetics, safety and tolerability of a varenicline patch applied once daily to the skin for 14 days.

Timeline

Start
2010-11
Primary completion
2011-03
Completion
2011-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Varenicline Small molecule 12 mg Topical
Subject Varenicline Small molecule 18 mg Topical
Subject Varenicline Small molecule 24 mg Topical
Subject Varenicline Small molecule 36 mg Topical

Indications

No indication recorded.